Successful Pregnancy Outcome in a Patient with Juvenile Idiopathic Arthritis in Adulthood, Amyloid A Amyloidosis, and Chronic Kidney Disease Using Tocilizumab with Strict Blood Pressure Control
- PMID: 37779073
- PMCID: PMC11116017
- DOI: 10.2169/internalmedicine.1951-23
Successful Pregnancy Outcome in a Patient with Juvenile Idiopathic Arthritis in Adulthood, Amyloid A Amyloidosis, and Chronic Kidney Disease Using Tocilizumab with Strict Blood Pressure Control
Abstract
Pregnancies with chronic kidney disease (CKD) and high disease activity in rheumatic diseases are high-risk events with adverse outcomes for both the mother and fetus. We herein report a 35-year-old woman with juvenile idiopathic arthritis (JIA), amyloid A (AA) amyloidosis related to JIA, and CKD stage G4A2 who wished to have children. She achieved a successful pregnancy, even in the presence of these multiple risk factors, using tocilizumab to control the disease activity of JIA and AA amyloidosis, along with antihypertensive drugs to control her blood pressure before and during pregnancy.
Keywords: Juvenile idiopathic arthritis; amyloid A amyloidosis; chronic kidney disease; pregnancy; rheumatic diseases; tocilizumab.
Conflict of interest statement
Figures
![Figure 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11116017/bin/1349-7235-63-1311-g001.gif)
![Figure 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11116017/bin/1349-7235-63-1311-g002.gif)
![Figure 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11116017/bin/1349-7235-63-1311-g003.gif)
![Figure 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11116017/bin/1349-7235-63-1311-g004.gif)
Similar articles
-
Tocilizumab preserves renal function in rheumatoid arthritis with AA amyloidosis and end-stage kidney disease: Two case reports.Clin Nephrol. 2021 Jan;95(1):54-61. doi: 10.5414/CN109971. Clin Nephrol. 2021. PMID: 33155543 Free PMC article.
-
Prevalence of and factors associated to chronic kidney disease and hypertension in a cohort of children with juvenile idiopathic arthritis.Eur J Pediatr. 2021 Feb;180(2):655-661. doi: 10.1007/s00431-020-03792-4. Epub 2020 Aug 29. Eur J Pediatr. 2021. PMID: 32860100
-
Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis.Rheumatol Int. 2020 Jan;40(1):153-159. doi: 10.1007/s00296-019-04363-z. Epub 2019 Jul 4. Rheumatol Int. 2020. PMID: 31273457 Review.
-
Clinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review.BMC Nephrol. 2017 May 12;18(1):159. doi: 10.1186/s12882-017-0573-y. BMC Nephrol. 2017. PMID: 28499374 Free PMC article. Review.
-
Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis.Arthritis Rheum. 2006 Sep;54(9):2997-3000. doi: 10.1002/art.22118. Arthritis Rheum. 2006. PMID: 16947531
References
-
- Giles I, Yee CS, Gordon C. Stratifying management of rheumatic disease for pregnancy and breastfeeding. Nat Rev Rheumatol 15: 391-402, 2019. - PubMed
-
- Sammaritano LR, Bermas BL, Chakravarty EE, et al. . 2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Care Res (Hoboken) 72: 461-488, 2020. - PubMed
-
- Konaka H, Hashimoto N, Ishizu M, et al. . Tocilizumab improves gross hematuria in an adult patient with AA amyloidosis of the urinary bladder secondary to juvenile idiopathic arthritis. Clin Rheumatol 29: 45-51, 2017.
-
- Lachmann HJ, Goodman HJ, Gilbertson JA, et al. . Natural history and outcome in systemic AA amyloidosis. N Engl J Med 356: 2361-2371, 2007. - PubMed